Institut Pasteur Korea to screen Pfizer compound library

Institut Pasteur Korea said on December 7 that it has entered into a Collaborative Agreement with the Drugs for Neglected Diseases Initiative (DNDi), centered on the use of Pfizer’s compound library, for the identification and development of safe, effective and affordable new treatments for patients suffering from neglected diseases such as visceral leishmaniasis (VL) and Chagas’ disease.

T...